Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Genital Herpes”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)UnknownNCT00005663
What this trial is testing

Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Who this might be right for
Herpes SimplexHIV InfectionsHerpes Genitalis
Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00477334
What this trial is testing

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Who this might be right for
Genital Herpes
Novartis 463
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Testing effectiveness (Phase 2)UnknownNCT04714060
What this trial is testing

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 44
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Large-scale testing (Phase 3)Study completedNCT01281007
What this trial is testing

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

Who this might be right for
GENITAL HERPES
EMS 150
Large-scale testing (Phase 3)Study completedNCT00164424
What this trial is testing

Episodic Acyclovir Therapy for Genital Ulcers

Who this might be right for
HIV InfectionsUlcerHerpes Simplex
Centers for Disease Control and Prevention 613
Not applicableStudy completedNCT00002186
What this trial is testing

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals 400
Not applicableStudy completedNCT04950712
What this trial is testing

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Who this might be right for
Herpes Genitalis
GlaxoSmithKline 537
Testing effectiveness (Phase 2)Study completedNCT01687595
What this trial is testing

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex Type 2
Agenus Inc. 80
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Large-scale testing (Phase 3)Study completedNCT00306787
What this trial is testing

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Who this might be right for
Genital Herpes
Novartis Pharmaceuticals 1,179
Early research (Phase 1)Ended earlyNCT04222985
What this trial is testing

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

Who this might be right for
Genital Herpes
Sanofi Pasteur, a Sanofi Company 24
Early research (Phase 1)UnknownNCT05393440
What this trial is testing

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Zhongnan Hospital 18
Testing effectiveness (Phase 2)Study completedNCT05298254
What this trial is testing

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex
GlaxoSmithKline 505
Testing effectiveness (Phase 2)UnknownNCT00005025
What this trial is testing

Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
John Stoddard Cancer Center at Iowa Methodist Medical Center
Post-approval studies (Phase 4)Ended earlyNCT04235322
What this trial is testing

Study of 2LHERP® in Genital Herpes Infections

Who this might be right for
Herpes Simplex, Genital
Labo'Life 6
Early research (Phase 1)Study completedNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 103
Not applicableStudy completedNCT05500053
What this trial is testing

The Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Who this might be right for
Genital HerpesPatient Engagement
Rational Vaccines Inc 68
Large-scale testing (Phase 3)Study completedNCT00171990
What this trial is testing

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes
Novartis 1,461
Load More Results